Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,474 INR | -0.72% | +6.50% | -4.03% |
14/05 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
13/05 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.03% | 247.79Cr | |
-16.80% | 878.61Cr | |
+65.89% | 419.12Cr | |
-42.54% | 229.17Cr | |
-6.30% | 196.68Cr | |
-19.90% | 155.64Cr | |
-41.24% | 121.88Cr | |
+10.26% | 112.64Cr | |
+18.74% | 93Cr | |
-11.26% | 91Cr |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q1 2024 Earnings Call, Jul 27, 2023